Inspection Record

Central Admixture Pharmacy Services Inc — FDA 483 Findings

US FDAInspected 2021-05-24Published 2021-09-24 4 findingsAseptic processing and sterility assuranceOther quality system

Inspectors Claire M MindenThe inspectors who signed the published document.Inspector lookup

View the regulator's official source The source document is always the basis for judgement.

Findings

1Aseptic processing and sterility assurance

Personnel touched equipment or other surfaces located outside of the ISO 5 classified aseptic processing area with gloved hands and then engaged in aseptic processing without changing or sanitizing gloves.

2Aseptic processing and sterility assurance

The ISO 5 classified aseptic processing areas had difficult to clean equipment or surface.

3Other quality system

Disinfectant contact time (also known as "dwell time") and coverage of the item being disinfected were insufficient to achieve adequate levels of disinfection.

4Aseptic processing and sterility assurance

You did not make adequate product evaluation and take remedial action where actionable microbial contamination was found to be present in the ISO 5 classified aseptic processing area during aseptic production.

About this record

Extracted automatically from the document US FDA published on 2021-09-24. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Other records for this company

Central Admixture Pharmacy Services Inc findings history — including this company's other documents US FDA documents, 2021 Go to Findings search